Skip to main content

Table 3 Trial feasibility criteria as per the funder request

From: Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial

Criteria

Target

Number of sites open to recruitment

7

Ratio of patients consented/eligible

≥ 20%

Number of participants randomised

≥ 50

Compliance with intervention

Subjective, percentage of non-compliers to be considered

Loss to follow-up

≤ 30%

Safety

Subjective, all adverse events and serious adverse events considered